Arbutus Biopharma
ABUS
ABUS
48 hedge funds and large institutions have $100M invested in Arbutus Biopharma in 2014 Q3 according to their latest regulatory filings, with 21 funds opening new positions, 6 increasing their positions, 18 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
48
Holders Change
+9
Holders Change %
+23.08%
% of All Funds
1.39%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
21
Increased
6
Reduced
18
Closed
12
Calls
$11.6M
Puts
$19.1M
Net Calls
-$7.51M
Net Calls Change
-$7.92M
Top Buyers
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
NFA
51
Nationwide Fund Advisors
Columbus,
Ohio
| – | -$869K | -66,552 | Closed |
|
|
IGIM
52
I.G. Investment Management
Winnipeg,
Manitoba, Canada
| – | -$831K | -63,750 | Closed |
|
53
Stifel Financial
St. Louis,
Missouri
| – | -$443K | -33,950 | Closed |
|
|
DCM
54
Driehaus Capital Management
Chicago,
Illinois
| – | -$443K | -33,932 | Closed |
|
|
CS
55
Credit Suisse
Zurich,
Switzerland
| – | -$440K | -33,688 | Closed |
|
|
TC
56
TFS Capital
West Chester,
Pennsylvania
| – | -$400K | -30,625 | Closed |
|
57
Group One Trading
Chicago,
Illinois
| – | -$278K | -21,264 | Closed |
|
|
EA
58
Emerald Advisers
Leola,
Pennsylvania
| – | -$142K | -10,847 | Closed |
|
|
SIM
59
Spark Investment Management
New York
| – | -$134K | -10,300 | Closed |
|
60
Acadian Asset Management
Boston,
Massachusetts
| – | -$76K | -5,799 | Closed |
|